Downregulation of GSTK1 Is a Common Mechanism Underlying Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy and is associated with a number of potential outcomes, including impaired diastolic function, heart failure, and sudden cardiac death. Various etiologies have been described for HCM, including pressure overload and mu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Sasagawa, Shota, Nishimura, Yuhei, Okabe, Shiko, Murakami, Soichiro, Ashikawa, Yoshifumi, Yuge, Mizuki, Kawaguchi, Koki, Kawase, Reiko, Okamoto, Ryuji, Ito, Masaaki, Tanaka, Toshio
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2016
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4905960/
https://ncbi.nlm.nih.gov/pubmed/27378925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00162
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky